K. Heran Darwin
- Molecular Biology top 5%
- Infectious Diseases top 1%
- Epidemiology top 5%
- Oncology top 5%
- Endocrinology top 0.5%
- Co-authors
- Virginia L. MillerCarl NathanMichael J. PearceHuilin LiSteven P. GygiRichard A. FestaMarie I. SamanovicSabine Ehrt
- Topics
- Ubiquitin and proteasome pathways (35 papers)Biochemical and Molecular Research (29 papers)Peptidase Inhibition and Analysis (18 papers)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
K. Heran Darwin
79 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 110
- Molecular Biology 2.5k
- Infectious Diseases 1.0k
- Epidemiology 870
- Oncology 706
- Endocrinology 608
Countries citing papers authored by K. Heran Darwin
This map shows the geographic impact of K. Heran Darwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Heran Darwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Heran Darwin more than expected).
Fields of papers citing papers by K. Heran Darwin
This network shows the impact of papers produced by K. Heran Darwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Heran Darwin. The network helps show where K. Heran Darwin may publish in the future.
Co-authorship network of co-authors of K. Heran Darwin
This figure shows the co-authorship network connecting the top 25 collaborators of K. Heran Darwin. A scholar is included among the top collaborators of K. Heran Darwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Heran Darwin. K. Heran Darwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 5 | |
| 3 | 6 | |
| 4 | 20 | |
| 5 | 109 | |
| 6 | 24 | |
| 7 | 1 | |
| 8 | 37 | |
| 9 | 93 | |
| 10 | 31 | |
| 11 | 13 | |
| 12 | 212 | |
| 13 | 119 | |
| 14 | 102 | |
| 15 | 74 | |
| 16 | 311 | |
| 17 | 107 | |
| 18 | 415 | |
| 19 | 185 | |
| 20 | 111 |
About K. Heran Darwin
K. Heran Darwin is a scholar working on Infectious Diseases, Endocrinology and Molecular Biology, having authored 79 papers that have together received 4.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (35 papers), Biochemical and Molecular Research (29 papers) and Peptidase Inhibition and Analysis (18 papers). The work is most often cited by research in Endocrinology (608 citations), Molecular Medicine (293 citations) and Infectious Diseases (1.0k citations). K. Heran Darwin has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Virginia L. Miller, Carl Nathan, Michael J. Pearce, Huilin Li, Steven P. Gygi, Richard A. Festa, Marie I. Samanovic, Sabine Ehrt, Kristin E. Burns and Julian Mintseris. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.